Search results
Showing results for
Scientists in the Kennedy Institute, NDORMS show anti-TNF inhibits the cells responsible for Dupuytren’s disease.
Srinivasa Rao Rao
MBBS, MS (res), DPhil, AFHEA Srinivasa Rao Rao - Senior Researcher in Cancer Genomics
Marie-Madlen Pust
Marie-Madlen Pust - Kennedy Trust for Rheumatology Research (KTRR) Group Leader in Microbiome Studies
Muhammad Dawood
Muhammad Dawood - Senior Bioinformatician in Single-cell and Spatial Multiomics
Beata Giglio
Beata Giglio - Programme Manager for Functional Genomics Cluster / Project Manager for Health Economics and Outcomes Research Group
Grigore-Aristide Gafencu
Grigore-Aristide Gafencu - Senior Bioinformatician in Single-cell and Spatial Multiomics
Florian Groelly
Florian Groelly - Programme Manager – Industry Liaison in Experimental Medicine
Janine Crispin
Janine Crispin - Head of Operations, Kennedy Institute of Rheumatology
Toulza Frederic
Toulza Frederic - Senior Postdoctoral Research Assistant in Immunology
Giuseppe Abbate
Giuseppe Abbate - Research Assistant in Immunology and Inflammation
Meet the team
-
Jagdeep Nanchahal
Professor of Hand, Plastic and Reconstructive Surgery
-
Sir Marc Feldmann FRS
Emeritus Professor
-
Fiona Powrie FRS
Professor of Musculoskeletal Sciences and Director of the Kennedy Institute
PROFESSOR Jagdeep Nanchahal talks about the Trial
Read the paper
The findings are published on line in the journal EBioMedicine, published by The Lancet.
FIND OUT ABOUT THE TRIAL
Funded by
Funding for the drug was provided by 180 Therapeutics.